Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.

Also called NCT01747356

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,000 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01747356
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01747356. Allocation not applicable; no masking; primary purpose treatment. Start 2013-02 (registry gives no type); primary completion 2015-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions
Acronym
RESOLUTE-DM
Condition
Diabetes
Intervention (Device)
Resolute stent treatment
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01747356
Content hash
6ec1a84f5a70245ed23382aa12580d15ac550378e34e7f47f2a9cbd7a5c16e6c